Distinguished in Neonatal Hemochromatosis

Kenji Matsumoto

Tokyo, JP 
Distinguished in Neonatal Hemochromatosis
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Kenji Matsumoto practices in Tokyo, Japan. Mr. Matsumoto is rated as a Distinguished expert by MediFind in the treatment of Neonatal Hemochromatosis. His top areas of expertise are Asthma, Atopic Dermatitis, Neonatal Hemochromatosis, Bone Marrow Transplant, and Percutaneous Coronary Intervention (PCI).

His clinical research consists of co-authoring 507 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Neonatal Hemochromatosis.

Gender
Male

Locations

Tokyo, Japan
Other Locations
Setagaya, Japan
Kagoshima, 8900065, Japan
Kanazawa, Japan
Yokohama, Japan
Nonoichi, 9218836, Japan
Chiyoda, 1007017, Japan
Osaka, Japan
Kobe, Japan
Machida, 1948610, Japan
Omihachiman, Japan
Utsunomiya, 3210974, Japan
Sasebo, 8578511, Japan
Tamagawa, Japan
Izumi, 5940073, Japan
Shimotsuke, Japan
Nishi, 8190395, Japan
Sayama, Japan
Okura, 1578535, Japan
Suita, Japan
Kashihara, Japan
Nagoya, Japan
Kasuga, 8168580, Japan
Tokushima, Japan
Japan
Fukuoka, Japan
Tamagawa, Japan
Asahi, 5458585, Japan
Kyoto, Japan
Gifu-shi, Japan
Saitama, 3388570, Japan
Chiba, Japan
Tokorozawa, 3598511, Japan
Yokkaichi, Japan
Asahimachi, 5458586, Japan
Sugitani, 9300194, Japan
Kawaguchi, Japan
Higashi, 8128581, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

507 Total Publications

Intrauterine high-dose intravenous immunoglobulin therapy during pregnancy for women with a history of pregnancy ending in documented neonatal haemochromatosis (NH001): study protocol.
Intrauterine high-dose intravenous immunoglobulin therapy during pregnancy for women with a history of pregnancy ending in documented neonatal haemochromatosis (NH001): study protocol.
Journal: BMJ open
Published: October 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Matsumoto's expertise for a condition
ConditionClose
    View All 21 Advanced Conditions
    View All 91 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile